Heron Therapeutics Stock Price & Analysis
1,196 Followers
HRTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.19 - $12.79
Previous Close$3.86
Volume3.65M
Average Volume (3M)3.38M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$83.54M
Total Debt (Recent Filing)$16.21M
P/E Ratio-1.7
Beta0.66
Next EarningsNov 09, 2022
EPS Estimate-$0.38
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$7.75
EPS (TTM)-2.23
Shares Outstanding118,761,192
R-Squared0.13
Standard Deviation0.16
10 Day Avg. Volume5,430,560
30 Day Avg. Volume3,383,336
P/B Ratio-21.75
P/S Ratio4.83
P/CF RatioN/A
P/FCF Ratio-2.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside92.79% Upside
Rating ConsensusStrong Buy
Alpha-0.02
Number of Analyst Covering3
Heron Therapeutics News
P/E Ratio Range
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HRTX FAQ
What was Heron Therapeutics’s price range in the past 12 months?
Heron Therapeutics lowest stock price was $2.19 and its highest was $12.79 in the past 12 months.
What is Heron Therapeutics’s market cap?
Currently, no data Available
When is Heron Therapeutics’s upcoming earnings report date?
Heron Therapeutics’s upcoming earnings report date is Nov 09, 2022 which is in 42 days.
How were Heron Therapeutics’s earnings last quarter?
Heron Therapeutics released its earnings results on Aug 09, 2022. The company reported -$0.55 earnings per share for the quarter, missing the consensus estimate of -$0.536 by -$0.014.
Is Heron Therapeutics overvalued?
According to Wall Street analysts Heron Therapeutics’s price is currently Undervalued.
Does Heron Therapeutics pay dividends?
Heron Therapeutics does not currently pay dividends.
What is Heron Therapeutics’s EPS estimate?
Heron Therapeutics’s EPS estimate is -$0.38.
How many shares outstanding does Heron Therapeutics have?
Heron Therapeutics has 102,632,160 shares outstanding.
What happened to Heron Therapeutics’s price movement after its last earnings report?
Heron Therapeutics reported an EPS of -$0.55 in its last earnings report, missing expectations of -$0.536. Following the earnings report the stock price went up 15.126%.
Which hedge fund is a major shareholder of Heron Therapeutics?
Among the largest hedge funds holding Heron Therapeutics’s share is Fisher Asset Management LLC. It holds Heron Therapeutics’s shares valued at 505K.
---
Heron Therapeutics Stock Analysis
Smart ScoreNeutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target: $7.75
Blogger Sentiment
Bullish
HRTX Sentiment 66% Sector Average 70%
Hedge Fund Holdings
▲ Increased
By 300.0 Shares Last Quarter.
Insider Transactions
N/A
Currently Not Enough Data Available
Retail Investors
Positive
Last 7 Days ▲ 1.4% Last 30 Days ▲ 2.2%
News Sentiment
Neutral
Bullish 50% Bearish 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-69.34%
12-Months-Change
Fundamentals
Return on Equity
-328.53%
Trailing 12-Months
Asset Growth
-39.65%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Heron Therapeutics
Heron Therapeutics, Inc. is a biotechnology company, which develops pharmaceutical products for patients suffering from cancer. The company develops products by using its proprietary Biochronomer polymer based drug delivery technology. Its products include SUSTOL, Pipeline, Cinvanti and HTX-011. The company has additional clinical and preclinical-stage programs in the area of pain management, all of which utilize its bio erodible, injectable and implantable delivery systems. Heron Therapeutics was founded in February 1983 and is headquartered in Redwood City, CA.
---
---